UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 42

Sortiert nach

Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversion

Nature communications, 2020-07, Vol.11 (1), p.3774-3774, Article 3774

2020

Volltextzugriff (PDF)

Pseudoacrocyanosis: a case for telemedicine in rheumatology

Rheumatic & musculoskeletal diseases open, 2022-09, Vol.8 (2), p.e002573

2022

Volltextzugriff (PDF)

Effects of casirivimab/imdevimab on systemic and mucosal immunity against SARS-CoV-2 in B-cell depleted patients with autoimmune rheumatic diseases refractory to vaccination

Rheumatic & musculoskeletal diseases open, 2022-05, Vol.8 (1), p.e002323

2022

Volltextzugriff (PDF)

Humoral and Cellular Immune Responses to SARS–CoV‐2 Infection and Vaccination in Autoimmune Disease Patients With B Cell Depletion

Arthritis & rheumatology (Hoboken, N.J.), 2022-01, Vol.74 (1), p.33-37

2022

Volltextzugriff (PDF)

Relapse rates in patients with rheumatoid arthritis in stable remission tapering or stopping antirheumatic therapy: interim results from the prospective randomised controlled RETRO study

Annals of the rheumatic diseases, 2016-01, Vol.75 (1), p.45-51

2016

Volltextzugriff (PDF)

Tixagevimab/cilgavimab for the prevention of COVID-19 in vaccine-refractory patients with autoimmune diseases: a prospective cohort study

Rheumatology (Oxford, England), 2024-05, Vol.63 (5), p.1377-1383

2024

Volltextzugriff (PDF)

Prediction of disease relapses by multibiomarker disease activity and autoantibody status in patients with rheumatoid arthritis on tapering DMARD treatment

Annals of the rheumatic diseases, 2016-09, Vol.75 (9), p.1637-1644

2016

Volltextzugriff (PDF)

IgA anti-citrullinated protein antibodies are associated with flares during DMARD tapering in rheumatoid arthritis

Rheumatology (Oxford, England), 2022-05, Vol.61 (5), p.2124-2131

2022

Volltextzugriff (PDF)

Hard Palate Hyperpigmentation—a Rare Side Effect of Antimalarials

Arthritis & rheumatology (Hoboken, N.J.), 2018-01, Vol.70 (1), p.152-152

2018

Volltextzugriff (PDF)

Impact of Cytokine Inhibitor Therapy on the Prevalence, Seroconversion Rate, and Longevity of the Humoral Immune Response Against SARS–CoV‐2 in an Unvaccinated Cohort

Arthritis & rheumatology (Hoboken, N.J.), 2022-05, Vol.74 (5), p.783-790

2022

Volltextzugriff (PDF)

Risk of infections in rheumatoid arthritis patients treated with tocilizumab

Rheumatology (Oxford, England), 2012-05, Vol.51 (5), p.852-857

2012

Volltextzugriff (PDF)

Successful treatment of adult-onset Still's disease refractory to TNF and IL-1 blockade by IL-6 receptor blockade

Annals of the rheumatic diseases, 2011-02, Vol.70 (2), p.390-392

2011

Volltextzugriff (PDF)

Prevention of gonadal toxicity and preservation of gonadal function and fertility in young women with systemic lupus erythematosus treated by cyclophosphamide: The PREGO-Study

Autoimmunity reviews, 2006-04, Vol.5 (4), p.269-272

2006

Volltextzugriff (PDF)

Definition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus

Annals of the rheumatic diseases, 2002-12, Vol.61 (12), p.1065-1070

2002

Volltextzugriff (PDF)

Kallikrein genes are associated with lupus and glomerular basement membrane-specific antibody-induced nephritis in mice and humans

The Journal of clinical investigation, 2009-04, Vol.119 (4), p.911-923

2009

Volltextzugriff (PDF)

Sequelae of improved prognosis of SLE

Zeitschrift für Rheumatologie, 2002-10, Vol.61 (5), p.532-533

2002

Volltextzugriff (PDF)

The FcγRIIIA-F158 allele is a risk factor for the development of lupus nephritis: A meta-analysis

Kidney international, 2003-04, Vol.63 (4), p.1475-1482

2003

Volltextzugriff (PDF)

Polymorphisms in the Hsp70 gene locus are genetically associated with systemic lupus erythematosus

Annals of the rheumatic diseases, 2010-11, Vol.69 (11), p.1983-1989

2010

Volltextzugriff (PDF)

Fcγ receptor IIa, IIIa, and IIIb polymorphisms in German patients with systemic lupus erythematosus: association with clinical symptoms

Annals of the rheumatic diseases, 2002-09, Vol.61 (9), p.786-792

2002

Volltextzugriff (PDF)

Gibt es eine Indikation für TNFα-Antagonisten bei Kollagenosen?

Zeitschrift für Rheumatologie, 2003-06, Vol.62 (3), p.240-245

2003

Volltextzugriff (PDF)

Sensitive detection of plasma/serum DNA in patients with systemic lupus erythematosus

Autoimmunity (Chur, Switzerland), 2007-01, Vol.40 (4), p.307-310

2007

Volltextzugriff (PDF)

1 – 25 von 42

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(41)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(27)
Life Sciences & Biomedicine
(26)
Humans
(22)
Rheumatology
(20)
Female
(14)
Male
(11)
Adult
(9)
Biological And Medical Sciences
(9)
Medical Sciences
(9)
Risk Factors
(7)
Antirheumatic Agents - Therapeutic Use
(6)
Middle Aged
(6)
Rheumatoid Arthritis
(6)
Sle
(6)
Aged
(5)
Antibodies
(5)
Patients
(5)
Prospective Studies
(5)
Arthritis, Rheumatoid - Drug Therapy
(4)
Cohort Studies
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversion

Pseudoacrocyanosis: a case for telemedicine in rheumatology

Effects of casirivimab/imdevimab on systemic and mucosal immunity against SARS-CoV-2 in B-cell depleted patients with autoimmune rheumatic diseases refractory to vaccination

Physical Function of RA patients Tapering Treatment-A Post Hoc Analysis of the Randomized Controlled RETRO Trial

Humoral and Cellular Immune Responses to SARS–CoV‐2 Infection and Vaccination in Autoimmune Disease Patients With B Cell Depletion

Relapse rates in patients with rheumatoid arthritis in stable remission tapering or stopping antirheumatic therapy: interim results from the prospective randomised controlled RETRO study

Tixagevimab/cilgavimab for the prevention of COVID-19 in vaccine-refractory patients with autoimmune diseases: a prospective cohort study

Prediction of disease relapses by multibiomarker disease activity and autoantibody status in patients with rheumatoid arthritis on tapering DMARD treatment

IgA anti-citrullinated protein antibodies are associated with flares during DMARD tapering in rheumatoid arthritis

Hard Palate Hyperpigmentation—a Rare Side Effect of Antimalarials

Impact of Cytokine Inhibitor Therapy on the Prevalence, Seroconversion Rate, and Longevity of the Humoral Immune Response Against SARS–CoV‐2 in an Unvaccinated Cohort

Risk of infections in rheumatoid arthritis patients treated with tocilizumab

Antimodified protein antibody response pattern influences the risk for disease relapse in patients with rheumatoid arthritis tapering disease modifying antirheumatic drugs

Successful treatment of adult-onset Still's disease refractory to TNF and IL-1 blockade by IL-6 receptor blockade

Prevention of gonadal toxicity and preservation of gonadal function and fertility in young women with systemic lupus erythematosus treated by cyclophosphamide: The PREGO-Study

Definition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus

Intensity and longevity of SARS-CoV-2 vaccination response in patients with immune-mediated inflammatory disease: a prospective cohort study

Treatment tapering and stopping in patients with rheumatoid arthritis in stable remission (RETRO): a multicentre, randomised, controlled, open-label, phase 3 trial

Kallikrein genes are associated with lupus and glomerular basement membrane-specific antibody-induced nephritis in mice and humans

Sequelae of improved prognosis of SLE

The FcγRIIIA-F158 allele is a risk factor for the development of lupus nephritis: A meta-analysis

Polymorphisms in the Hsp70 gene locus are genetically associated with systemic lupus erythematosus

Fcγ receptor IIa, IIIa, and IIIb polymorphisms in German patients with systemic lupus erythematosus: association with clinical symptoms

Gibt es eine Indikation für TNFα-Antagonisten bei Kollagenosen?

Sensitive detection of plasma/serum DNA in patients with systemic lupus erythematosus

Suchergebnisse filtern